REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Capital expenditures, 2025
- $898M
- YoY, 2025
- +18.9%
- 5-year CAGR
- +7.9%
- 10-year CAGR
- +2.9%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $898M | +18.9% |
| 2024 | $756M | +5.2% |
| 2023 | $719M | +21.8% |
| 2022 | $590M | +6.9% |
| 2021 | $552M | −10.2% |
| 2020 | $615M | +43.1% |
| 2019 | $430M | +12.1% |
| 2018 | $383M | +40.5% |
| 2017 | $273M | −46.7% |
| 2016 | $512M | −24.5% |
| 2015 | $678M | +103.6% |
| 2014 | $333M | +113.0% |
| 2013 | $156M | +216.8% |
| 2012 | $49M | −13.8% |
| 2011 | $57M | −42.6% |
| 2010 | $100M | +2.4% |
| 2009 | $97M | +179.2% |
| 2008 | $35M | — |